184 related articles for article (PubMed ID: 6448572)
1. Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation.
Yoshida T; Matsuura S; Mayama M; Kameda Y; Kuwahara S
Antimicrob Agents Chemother; 1980 Mar; 17(3):302-12. PubMed ID: 6448572
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
Vuye A
Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
Goto S
Rev Infect Dis; 1982; 4 Suppl():S501-10. PubMed ID: 6218559
[TBL] [Abstract][Full Text] [Related]
4. The in vitro activity of moxalactam against 430 clinical, bacterial isolates.
Digranes A; Benonisen E; Dibb WL; Ostervold B
Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):69-72. PubMed ID: 6211028
[TBL] [Abstract][Full Text] [Related]
5. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity, efficacy, and pharmacology of moxalactam, a new beta-lactam antibiotic.
Snepar R; Poporad G; Romano J; Levison ME
Antimicrob Agents Chemother; 1981 Nov; 20(5):642-7. PubMed ID: 6459763
[TBL] [Abstract][Full Text] [Related]
7. In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
DeMaria A; Alvarez S; Klein JO; McCabe WR
Infection; 1980; 8 Suppl 3():S 261-7. PubMed ID: 6447671
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.
Tai M; Fukuoka Y; Yotsuji A; Kumano K; Takahata M; Mikami H; Yasuda T; Saikawa I; Mitsuhashi S
Antimicrob Agents Chemother; 1982 Nov; 22(5):728-34. PubMed ID: 6983861
[TBL] [Abstract][Full Text] [Related]
9. Role of the 7 alpha-methoxy and side-chain carboxyl of moxalactam in beta-lactamase stability and antibacterial activity.
Murakami K; Yoshida T
Antimicrob Agents Chemother; 1981 Jan; 19(1):1-7. PubMed ID: 6454378
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
Downs JT; Andriole VT
Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 Jun; 17(6):937-42. PubMed ID: 6250470
[TBL] [Abstract][Full Text] [Related]
12. SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
Tsuchiya K; Kida M; Kondo M; Ono H; Takeuchi M; Nishi T
Antimicrob Agents Chemother; 1978 Oct; 14(4):557-68. PubMed ID: 718154
[TBL] [Abstract][Full Text] [Related]
13. Comparative activities of moxalactam (LY 127935) a new semisynthetic 1-oxa-beta lactam antibiotic with 7 other antibiotics against type b Haemophilus influenzae.
Chu ML; Harms JL; Liu C
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Sep; 14(3):146-55. PubMed ID: 6456875
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Verbist L
Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli.
Greenwood D; Eley A; Pearson N; O'Grady F
J Antimicrob Chemother; 1981 Apr; 7(4):353-62. PubMed ID: 6265424
[TBL] [Abstract][Full Text] [Related]
16. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Reimer LG; Mirrett S; Reller LB
Antimicrob Agents Chemother; 1980 Mar; 17(3):412-6. PubMed ID: 6448577
[TBL] [Abstract][Full Text] [Related]
17. Biological and chemotherapeutic studies on three semisynthetic cephamycins.
Uri JV; Actor P; Guarini JR; Phillips L; Pitkin D; Demarinis RM; Weisbach JA
J Antibiot (Tokyo); 1978 Jan; 31(1):82-91. PubMed ID: 627526
[TBL] [Abstract][Full Text] [Related]
18. Synthetic studies on beta-lactam antibiotics. Part 101. Synthesis of 7beta-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7alpha-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]-methyl]-1-oxa-1-dethia-3-cephem-4-carboxylic acid disodium salt (6059-S) and its related 1-oxacephems.
Narisada M; Yoshida T; Onoue H; Ohtani M; Okada T; Tsuji T; Kikkawa I; Haga N; Satoh H; Itani H; Nagata W
J Med Chem; 1979 Jul; 22(7):757-9. PubMed ID: 448673
[No Abstract] [Full Text] [Related]
19. [Cefotetan, a new cephamycin antibiotic: in vitro and in vivo antibacterial activities (author's transl)].
Yano K; Suzaki K; Saito M; Toda M; Naito S; Ohmi Y
Jpn J Antibiot; 1982 Feb; 35(2):438-59. PubMed ID: 6953260
[TBL] [Abstract][Full Text] [Related]
20. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
